Northwestern’s buzzer beater moves to finals in ‘Best Play’ category

SHARE Northwestern’s buzzer beater moves to finals in ‘Best Play’ category
michigan_northwestern_basketball.jpg

Northwestern center Dererk Pardon, left, looks to the basket for the game winning-shot against Michigan guard Derrick Walton Jr during the second half of an NCAA college basketball game Wednesday, March 1, 2017, in Evanston, Ill. Northwestern won 67-65. (AP Photo/Nam Y. Huh) ORG XMIT: ILNH112

Northwestern men’s basketball team’s buzzer beater advanced to the finals in voting for the “Best Play” category in the ESPY awards.

Nathan Taphorn’s thrilling full-court pass to Dererk Pardon for a game-winning layup defeated Michigan on March 1. The play was seeded No. 4 among the 16 plays and has advanced through the two rounds of voting in the bracket-style format to reach the finals.

The other three nominees are a catch by the New England Patriots’ Julian Edelman in the Super Bowl, a game-winning shot by South Carolina to defeat UConn in the Women’s Final Four and a pass from Aaron Rodgers to Jared Cook in the Green Bay Packers’ NFL playoff win over the Dallas Cowboys.

The voting remains underway and fans can cast their vote here. The 2017 ESPYS will be July 12 beginning at 7 p.m. and televised on Ch. 7.

The Latest
The aim is to give students who might not initially see themselves going to a four-year school a boost that might help them eventually get a bachelor’s degree, as few two-year students do now.
Parent company Global Tetrahedron has big plans to diversify the satire news website’s revenue streams and bring back a print edition
Girls says the man is angry that she stood up for her mom in a disagreement about the couple’s sex and drinking habits.
Trout Unlimited’s Trout In The Classroom teaches young students about fish and the aquatic environment, capped by a day trip to get all wet.
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess doses of a drug at excess costs,” says Dr. Mark Ratain.